Only the three transacted names get rows. Mastercard, S&P Global and Novo Nordisk appear once as examples of "Quality Companies trading at decade low valuation levels" — no stance is argued and they get no row; FlightSafety, See's Candies, Berkshire, Markel and "airlines" appear as Buffett-taxonomy illustrations. Research legend: QT Qualtrim · SA Seeking Alpha · STK Stock Analysis. Written post with no timestamps — the At link opens the article.
| Ticker | Name | Research | View | What he said | At |
|---|---|---|---|---|---|
| V | Visa Inc. | QT · SA · STK · FA | Positive | Adding $20,000 — 60 shares at a limit price of $337. "Visa is the definition of Buffett's 'Great' business. It requires virtually zero extra capital to process an extra million transactions. It's a capital-light compounder with a very strong network effect. Merchants are forced to accept it, and consumers demand to use it." Because it needs little capital and runs high margins, "they generate a lot of Free Cash Flow that it uses to consistently buy back its own shares." | read ↗ |
| KNSL | Kinsale Capital | QT · SA · STK · FA | Positive | Adding $20,000 — 65 shares at a limit price of $330. An E&S insurer that writes "the unique, hard-to-place risks that standard insurance companies run away from." The moat is focus plus own-built technology: "they have lower costs than their competition… better data and can quote policies faster and more accurately. The proof is in their very low combined ratio" — ~77% against peers like Markel at ~95%. Bought deliberately into weakness: "The insurance market is currently going through a soft market. I think today's valuation levels provide amazing opportunities." | read ↗ |
| AMP | Ameriprise Financial | QT · SA · STK · FA | Positive | Adding $10,000 — 22 shares at a limit price of $460. "A leading diversified financial services firm with $1.2 trillion in assets under management and administration. Wealth management is an incredibly sticky business. Once clients onboard and build a relationship with an advisor, they rarely leave, which creates high switching costs and a strong moat." Fee-driven, high margin and very low capital intensity, so "you get another capital-light business that generates tons of Free Cash Flow… It's a clear cannibal stock. Right now, the shareholder yield (dividends + buybacks) is over 8%." | read ↗ |
All three were already disclosed Very Strong convictions in April; this issue converts conviction into size. Note the sizing asymmetry — $20k / $20k / $10k — and that every add carries a hard limit price rather than a market order. The published conclusion masks the prices as "Buy for $xx" in its summary block while the body states them in full.
A jargon-free summary of the thesis behind each argued name. (Renders on each name's consolidated page.)
Visa does not lend money or issue cards. It owns the wires that carry a card payment from the shopper's bank to the shop's bank, and takes a sliver of each transaction. The reason Slegers is buying more is a very specific property: handling another million payments costs Visa essentially nothing extra. There is no factory to build, no inventory to stock, no extra staff to hire. That is exactly what Buffett meant by a "great" business as opposed to a merely good one — profit grows without the owner having to put fresh money in.
The protection around it is that a payment network is only useful if both shops and shoppers are already on it, and each side joins because the other is there. Slegers puts it bluntly from both sides: merchants are forced to accept Visa, and consumers demand to use it. Because the cash the business throws off has nowhere better to go, Visa spends it buying back its own shares, so each remaining share owns a larger slice of the same tollbooth.
The action here is a purchase, not an opinion: $20,000, sixty shares, and he will not pay more than $337 for them.
Kinsale insures the awkward risks that ordinary insurers decline — the odd property, the hard-to-price liability. Those policies are written one at a time rather than off a standard rate card, so an underwriter who is genuinely good at pricing them can charge properly for the risk.
The scoreboard for an insurer is the combined ratio: of every dollar of premium collected, how many cents go out again as claims and running costs. Below 100 means the insurance itself made money before any investment income. Kinsale runs at roughly 77 cents; a well-regarded peer like Markel is near 95. That twenty-cent gap is the whole thesis, and Slegers traces it to two choices — doing nothing but excess-and-surplus business, and building its own software from scratch instead of stitching together acquired systems, which makes it cheaper and faster to quote a policy accurately.
The timing is deliberately uncomfortable. Insurance prices are currently falling because competitors have piled in — a "soft market" — and that is normally when insurance shares are avoided. His view is that the soft patch is a cycle, not a change in Kinsale's advantage, so the depressed valuation is the opportunity. He adds $20,000, sixty-five shares, capped at $330.
Ameriprise is a wealth manager — a large network of financial advisers looking after $1.2 trillion of clients' money, charging a fee on the balances they oversee. The moat is human rather than technological: once someone has handed their retirement savings to an adviser they trust and told them everything about their family finances, moving elsewhere is a genuine ordeal, so clients rarely leave.
Because the revenue is fees rather than lending, and because the business needs very little capital of its own to operate, almost all the profit turns into spare cash. Ameriprise hands that back through dividends and by relentlessly buying its own shares — the pattern Slegers calls a "cannibal stock," a company steadily eating its own share count so that continuing owners end up with a bigger claim on the same profits. Between dividends and buybacks the shareholder yield is running above 8% a year.
He adds $10,000 here — half the size of the other two — twenty-two shares at a limit of $460.
Summary derived from the archived Compounding Quality post (text in transcript.txt) for personal study. Not investment advice. © Compounding Quality / Pieter Slegers for source material.